Ageing population and new diseases are requiring the development of novel therapeutical
strategies. 3D bioprinting an novel application domain of additive manufacturing emerged …

The tumor microenvironment is highly complex owing to its heterogeneous composition and
dynamic nature. This makes tumors difficult to replicate using traditional 2D cell culture …

Tissue/organ shortage is a major medical challenge due to donor scarcity and patient
immune rejections. Furthermore, it is difficult to predict or mimic the human disease condition …

Escalating cases of organ shortage and donor scarcity worldwide are alarming reminders of
the need for alternatives to allograft tissues. Within the last three decades, research efforts in …

Three-dimensional (3D) printing represents the direct fabrication of parts layer-by-layer,
guided by digital information from a computer-aided design file without any part-specific …

Humans and animals lose tissues and organs due to congenital defects, trauma, and
diseases. The human body has a low regenerative potential as opposed to the urodele …

Abstract 3D bioprinting is an additive biomanufacturing technology having potential to fast-
forward the translational research, as it has the capability to fabricate artificial tissues and …

Three-dimensional (3D) bioprinting is a promising and rapidly evolving technology in the
field of additive manufacturing. It enables the fabrication of living cellular constructs with …

Abstract The field of 3-dimensional (3D) bioprinting has enjoyed rapid development in the
past few years for the applications in tissue engineering and regenerative medicine. In this …

Abstract Four-dimensional (4D) bioprinting, in which the concept of time is integrated with
three-dimensional (3D) bioprinting as the fourth dimension, has currently emerged as the …